A jury recently awarded 57 million Euros to a woman from California in a lawsuit where she claimed to have gotten cancer from using Johnson & Johnson powder over the years.
Deborah Giannecchini from Modesto, California, was diagnosed with ovarian cancer in 2012. She accused the pharmaceutical company of “negligent conduct” in the manufacturing and marketing of its talcum powder, which raised concerns over the effects of the product on its users’ health.
According to one of the lead attorneys, Jim Onder, the jury also found that the company has failed to warn the public about it, giving them more reason to rule in favour of Deborah.
“We are pleased the jury did the right thing,” Onder said in a statement following the St. Louis jury’s ruling. “They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.”
The verdict was made on Thursday and was ruled in favor of Giannecchini for $ 575,000 in medical damages, $ 2 million in compensatory damages, $ 65 million in punitive damages against Johnson and Johnson and $ 2.5 million in punitive damages against Imerys Talc, the talcum powder’s provider.
The International Agency for Research on Cancer classifies the use of talc for feminine hygiene as “possibly carcinogenic to humans,” while the National Toxicology Program has not fully reviewed it as a possible carcinogen.
In a statement provided to the St. Louis Post-Dispatch, J&J spokeswoman Carol Goodrich, said: ‘We deeply sympathies with the women and families impacted by ovarian cancer.
Post a Comment